Alder BioPharmaceuticals, Inc. Announces Exercise in Full of Underwriters’ Option to Purchase Additional 2.50% Convertible Senior Notes Due 2025

World News: . []

BOTHELL Wash Feb 13 2018 GLOBE NEWSWIRE -- Alder BioPharmaceuticals Inc NASDAQALDR a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced today that the underwriters of its pre...

More news and information about Alder Biopharmaceuticals, Inc.

Published By:

Globe Newswire: 15:47 GMT Tuesday 13th February 2018

Published: .

Search for other references to "alder" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us